Where does the pathological misfolding of the prion originate?

January 24, 2014
X-ray crystal structure of the human prion protein (in red) in complex with a Nanobody (in cyan). Credit: SISSA

"When they are healthy, they look like tiny spheres; when they are malignant, they appear as cubes" stated Giuseppe Legname, principal investigator of the Prion Biology Laboratory at the Scuola Internazionale Superiore di Studi Avanzati (SISSA) in Trieste, when describing prion proteins. Prions are "misfolded" proteins that cause a group of incurable neurodegenerative diseases, including spongiform encephalopathies (for example, mad cow diseases) and Creutzfeldt-Jakob disease. Legname and coworkers have recently published a detailed analysis of the early mechanisms of misfolding. Their research has just been published in the Journal of the American Chemical Society, the most authoritative scientific journal in the field.

Prions are unique infective agents —unlike viruses, bacteria, fungi and other parasites, prions do not contain either DNA or RNA. Despite their seemingly simple structure, they can propagate their pathological effects like wildfire, by "infecting" normal proteins. PrPSc (the pathological form of the ) can induce normal prion proteins (PrPC) to acquire the wrong conformation and convert into further disease-causing agents.

"For the first time, our experimental study has investigated the structural elements leading to the disease-causing conversion" explains Legname. "With the help of X-rays, we observed some synthetic prion proteins engineered in our lab by applying a new approach —we used nanobodies, i.e. small proteins that act as a scaffolding and induce prions to stabilize their structure". Legname and colleagues reported that misfolding originates in a specific part of the protein named "N-terminal". "The prion protein consists of two subunits. The C-terminal has a clearly defined and well-known structure, whereas the unstructured N-terminal is disordered, and still largely unknown. This is the very area where the early pathological misfolding occurs" adds Legname. "The looser conformation of the N-terminal likely determines a dynamic structure, which can thus change the protein shape".

"Works like ours are the first, important steps to understand the mechanisms underlying the pathogenic effect of prions" concludes Legname. "Elucidating the misfolding process is essential to the future development of drugs and therapeutic strategies against incurable ".

Explore further: The good side of the prion: A molecule that is not only dangerous, but can help the brain grow

More information: "Probing the N-Terminal β-Sheet Conversion in the Crystal Structure of the Human Prion Protein Bound to a Nanobody." Romany N. N. Abskharon, Gabriele Giachin, Alexandre Wohlkonig, Sameh H. Soror, Els Pardon, Giuseppe Legname, and Jan Steyaert, Journal of the American Chemical Society 2014 136 (3), 937-944. DOI: 10.1021/ja407527p.

Related Stories

Recombinant human prion protein inhibits prion propagation

October 9, 2013

Case Western Reserve University researchers today published findings that point to a promising discovery for the treatment and prevention of prion diseases, rare neurodegenerative disorders that are always fatal. The researchers ...

New approach to protecting prion protein from altering shape

July 18, 2013

A team of researchers from Case Western Reserve University School of Medicine have identified a mechanism that can prevent the normal prion protein from changing its molecular shape into the abnormal form responsible for ...

Prion-like proteins drive several diseases of aging

September 5, 2013

Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.

Recommended for you

Group uses its own 'toolset' to probe chemical responses

January 24, 2017

Using a novel chemical procedure developed in her lab, Yimon Aye and her group are helping to blaze a trail in the emerging field of precision medicine by targeting and modulating single proteins to achieve desired responses.

Scientists spin artificial silk from whey protein

January 23, 2017

A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's research light source PETRA III, the scientists could watch just how ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.